Physician profile
Cameron Beck
NPI 1679996433
$14,986.27
in general payments reported to CMS, 2019-2025
8 companies · $2,536 in 2025
The $2,536 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,573 · 2023: $8,565 · 2024: $1,313 · 2025: $2,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $6,787 · Food and Beverage: $3,575 · Travel and Lodging: $2,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $6,787.04 |
| Food and Beverage | $3,574.76 |
| Travel and Lodging | $2,051.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $11,544.28 | 2022-2025 | Mako, Variax, T2 |
| Pylant Medical | $2,433.02 | 2022-2023 | |
| Depuy Synthes Sales INC. | $413.64 | 2024-2025 | Na, Va-Lcp, Tfn-Advance |
| Biotissue Holdings INC. | $263.81 | 2023 | |
| Medical Device Business Services, INC. | $127.32 | 2024 | Surgicel Nu-Knit |
| Trimed, INC. | $97.11 | 2024 | |
| Medtronic, INC. | $72.53 | 2024 | Aquamantys(Tm) |
| Smith+Nephew, INC. | $34.56 | 2024 | Maverick, Spatial Frame, Evos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.